Briefly, the patient population included 1219 patients classified as APS according to Sidney criteria,1 285 patients with isolated persistently positive aPL and 1397 patients with a clinical suspicion of APS. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.